Ireland - English - HPRA (Health Products Regulatory Authority)

intrapharm laboratories limited - dihydrotachysterol - oral drops solution - 250 microgram/ml - dihydrotachysterol

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

esteve pharmaceuticals ltd - dihydrotachysterol - oral solution - 250microgram/1ml

Canada - English - Health Canada

sanofi-synthelabo canada inc - dihydrotachysterol - capsule - .125mg - dihydrotachysterol .125mg - vitamin d

Ireland - English - HPRA (Health Products Regulatory Authority)

abbott healthcare products ltd - dihydrotachysterol - tablets - 0.2 milligram

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

action chemical company proprietary limited - vitamin d (deshydrotachysterol) | glucose/galactose | nicotinic acid | calcium | cobalt | copper | iron | iodine | potassium | magnesium | manganese | sodium chloride | phosphorus | sulfur | zinc | vitamin a = retinyl | biotin-d | choline | inositol | vitamin b12 = cyanocobalamin | vitamin b5 = pantothenic acid-d | vitamin b2 = riboflavin | vitamin b1 = thiamine | vitamin b6 = pyridoxine | vitamin c = ascorbic acid | vitamin e-dl = alpha tocopherol-dl | vitamin k3 = menadione | vitamin m = folic acid = pga - nutrition & metabolism - dog | bitch | castrate | puppy - mineral and nutritional additive | acetonaemia | actinobacillosis | amino acid supplement | amino acids | bone fragility | bone growth | calcium supplement | cartilage strength | copper deficiency | egg shell | fatty acid deficiency | fatty liver | glucose | grass tetany | hepatotoxic drugs | hypocalcaemia | hypomagnesaemia | ileitis | iodine deficiencies | lactating | laxative | l-carnitine supplement | liver abscess | liver damage | lysine deficiencies | milk fever | mineral additive | myopathies | myositis syndrome | pangamic acid | phosphorous supplement | rickets | selenium deficiency | shell strength | soft bone disease | vitamin b12 | vitamin d supplement | vitamin e deficiencies | zinc deficiencies

Australia - English - Department of Health (Therapeutic Goods Administration)

southern cross pharma pty ltd - levothyroxine sodium, quantity: 0.2 mg - tablet, uncoated - excipient ingredients: maize starch; gelatin; croscarmellose sodium; magnesium stearate; lactose monohydrate - indicated for the management of demonstrated thyroid hormone deficiency. and also used to suppress thyrotropin (tsh) for the management of tsh-responsive tumours of the thyroid.

Australia - English - Department of Health (Therapeutic Goods Administration)

southern cross pharma pty ltd - levothyroxine sodium, quantity: 0.2 mg - tablet, uncoated - excipient ingredients: maize starch; gelatin; croscarmellose sodium; magnesium stearate; lactose monohydrate - indicated for the management of demonstrated thyroid hormone deficiency. and also used to suppress thyrotropin (tsh) for the management of tsh-responsive tumours of the thyroid.

Australia - English - Department of Health (Therapeutic Goods Administration)

southern cross pharma pty ltd - levothyroxine sodium, quantity: 0.15 mg - tablet, uncoated - excipient ingredients: maize starch; gelatin; croscarmellose sodium; magnesium stearate; lactose monohydrate - indicated for the management of demonstrated thyroid hormone deficiency. and also used to suppress thyrotropin (tsh) for the management of tsh-responsive tumours of the thyroid.

Australia - English - Department of Health (Therapeutic Goods Administration)

southern cross pharma pty ltd - levothyroxine sodium, quantity: 0.15 mg - tablet, uncoated - excipient ingredients: maize starch; gelatin; croscarmellose sodium; magnesium stearate; lactose monohydrate - indicated for the management of demonstrated thyroid hormone deficiency. and also used to suppress thyrotropin (tsh) for the management of tsh-responsive tumours of the thyroid.

Australia - English - Department of Health (Therapeutic Goods Administration)

southern cross pharma pty ltd - levothyroxine sodium, quantity: 0.125 mg - tablet, uncoated - excipient ingredients: maize starch; gelatin; croscarmellose sodium; magnesium stearate; lactose monohydrate - indicated for the management of demonstrated thyroid hormone deficiency. and also used to suppress thyrotropin (tsh) for the management of tsh-responsive tumours of the thyroid.